Selective Rab11 transport and the intrinsic regenerative ability of CNS axons

  1. Hiroaki Koseki
  2. Matteo Donegá
  3. Brian YH Lam
  4. Veselina Petrova
  5. Susan van Erp
  6. Giles SH Yeo
  7. Jessica CF Kwok
  8. Charles ffrench-Constant
  9. RIchard Eva  Is a corresponding author
  10. James Fawcett  Is a corresponding author
  1. University of Cambridge, United Kingdom
  2. University of Edinburgh, United Kingdom
  3. University of Leeds, United Kingdom

Abstract

Neurons lose intrinsic axon regenerative ability with maturation, but the mechanism remains unclear. Using an in-vitro laser axotomy model, we show a progressive decline in the ability of cut CNS axons to form a new growth cone and then elongate. Failure of regeneration was associated with increased retraction after axotomy. Transportation into axons becomes selective with maturation; we hypothesized that selective exclusion of molecules needed for growth may contribute to regeneration decline. With neuronal maturity Rab11 vesicles (which carry many molecules involved in axon growth) became selectively targeted to the somatodendritic compartment and excluded from axons. Their transport changed from bidirectional to retrograde. However, on overexpression Rab11 was mistrafficked into proximal axons, and these axons showed less retraction and enhanced regeneration after axotomy. These results suggest that the decline of intrinsic axon regenerative ability is associated with selective exclusion of key molecules, and that manipulation of transport can enhance regeneration.

Data availability

The following data sets were generated
    1. Lam B
    2. Koseki H
    (2016) Maturation of cortical neurons
    Publicly available at NCBI Gene Expression Omnibus (accession no: GSE92856).

Article and author information

Author details

  1. Hiroaki Koseki

    Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Matteo Donegá

    Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Brian YH Lam

    Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Veselina Petrova

    Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Susan van Erp

    MRC Centre of Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0883-2795
  6. Giles SH Yeo

    Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Jessica CF Kwok

    School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Charles ffrench-Constant

    MRC Centre for Regenerative Medicine, Centre for Multiple Sclerosis Research, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. RIchard Eva

    Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    re263@cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  10. James Fawcett

    John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    jf108@cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7990-4568

Funding

Medical Research Council (G1000864)

  • James Fawcett

Christopher and Dana Reeve Foundation (International Consortium)

  • James Fawcett

European Research Council (ECMneuro)

  • James Fawcett

GlaxoSmithKline International Scholarship

  • Hiroaki Koseki

Honjo International Scholarship Foundation

  • Hiroaki Koseki

Bristol Myers Squibb Graduate Studentship

  • Hiroaki Koseki

National Institute of Health Research (Cambridge Biomedical Research Centre)

  • James Fawcett

Czech ministry of education (CZ.02.1.01/0.0./0.0/15_003/0000419)

  • Jessica CF Kwok
  • James Fawcett

European Molecular Biology Organization (Long Term EMBO Fellowship (ALTF 1436-2015))

  • Susan van Erp

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India

Version history

  1. Received: March 18, 2017
  2. Accepted: August 7, 2017
  3. Accepted Manuscript published: August 8, 2017 (version 1)
  4. Accepted Manuscript updated: August 10, 2017 (version 2)
  5. Accepted Manuscript updated: August 30, 2017 (version 3)
  6. Version of Record published: September 22, 2017 (version 4)

Copyright

© 2017, Koseki et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,561
    views
  • 626
    downloads
  • 57
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hiroaki Koseki
  2. Matteo Donegá
  3. Brian YH Lam
  4. Veselina Petrova
  5. Susan van Erp
  6. Giles SH Yeo
  7. Jessica CF Kwok
  8. Charles ffrench-Constant
  9. RIchard Eva
  10. James Fawcett
(2017)
Selective Rab11 transport and the intrinsic regenerative ability of CNS axons
eLife 6:e26956.
https://doi.org/10.7554/eLife.26956

Share this article

https://doi.org/10.7554/eLife.26956

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Kenneth Chiou, Noah Snyder-Mackler
    Insight

    Single-cell RNA sequencing reveals the extent to which marmosets carry genetically distinct cells from their siblings.

    1. Cell Biology
    2. Neuroscience
    Mariana I Tsap, Andriy S Yatsenko ... Halyna R Shcherbata
    Research Article

    Mutations in Drosophila Swiss Cheese (SWS) gene or its vertebrate orthologue Neuropathy Target Esterase (NTE) lead to progressive neuronal degeneration in flies and humans. Despite its enzymatic function as a phospholipase is well-established, the molecular mechanism responsible for maintaining nervous system integrity remains unclear. In this study, we found that NTE/SWS is present in surface glia that forms the blood-brain-barrier (BBB) and that NTE/SWS is important to maintain its structure and permeability. Importantly, BBB glia-specific expression of Drosophila NTE/SWS or human NTE in the sws mutant background fully rescues surface glial organization and partially restores BBB integrity, suggesting a conserved function of NTE/SWS. Interestingly, sws mutant glia showed abnormal organization of plasma membrane domains and tight junction rafts accompanied by the accumulation of lipid droplets, lysosomes, and multilamellar bodies. Since the observed cellular phenotypes closely resemble the characteristics described in a group of metabolic disorders known as lysosomal storage diseases (LSDs), our data established a novel connection between NTE/SWS and these conditions. We found that mutants with defective BBB exhibit elevated levels of fatty acids, which are precursors of eicosanoids and are involved in the inflammatory response. Also, as a consequence of a permeable BBB, several innate immunity factors are upregulated in an age-dependent manner, while BBB glia-specific expression of NTE/SWS normalizes inflammatory response. Treatment with anti-inflammatory agents prevents the abnormal architecture of the BBB, suggesting that inflammation contributes to the maintenance of a healthy brain barrier. Considering the link between a malfunctioning BBB and various neurodegenerative diseases, gaining a deeper understanding of the molecular mechanisms causing inflammation due to a defective BBB could help to promote the use of anti-inflammatory therapies for age-related neurodegeneration.